|
Aug 7
|
MoneyMasters Podcast 8-7-25- Investors, Avoid this 6-Letter Word at ALL Costs
|
|
Aug 4
|
BBH- A Biotech Fund That's Ripe for a Major Turnaround
|
|
Jul 30
|
Top FDA Official’s Surprise Departure Means More Uncertainty for Biotech
|
|
Jul 30
|
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.
|
|
Jul 29
|
Liquidia's Yutrepia Drug Launch Expectations 'Overly Optimistic,' Oppenheimer Says
|
|
Jul 28
|
Biotech stocks dip as Trump administration mulls patent fee overhaul
|
|
Jul 16
|
Will Trump's Looming Tariffs Affect Pharma Profits In The Second Half Of 2025?
|
|
Jul 14
|
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
|
|
Jul 10
|
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
|
|
Jul 9
|
Wall Street waves off Trump's 200% pharma tariff threat
|
|
Jun 30
|
Should You Invest in the VanEck Biotech ETF (BBH)?
|
|
Jun 20
|
Gene Therapy Stocks Fall Amid More Turmoil at FDA
|
|
Feb 12
|
Why the 'best hedge' against the AI rally losing steam in 2025 is healthcare: Morning Brief
|
|
Dec 7
|
Wall Street Shrugs Off White House Proposal for Tackling High Drug Prices
|
|
Dec 1
|
Bank of America shares top sector trades for 2024
|
|
Nov 30
|
Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout
|
|
Oct 3
|
Vivek Ramaswamy’s Former Company Is Doing Just Fine Without Him
|